Suppr超能文献

慢性乙型病毒性肝炎与胰岛素抵抗的相关性。

Association of chronic viral hepatitis B with insulin resistance.

机构信息

Department of Family Medicine, Pusan National University School of Medicine, Beomeo-ri Mulgeum-eup, Yangsan 626-770, South Korea.

出版信息

World J Gastroenterol. 2012 Nov 14;18(42):6120-6. doi: 10.3748/wjg.v18.i42.6120.

Abstract

AIM

To investigate the relationship between chronic viral hepatitis B (CVHB) and insulin resistance (IR) in Korean adults.

METHODS

A total of 7880 adults (3851 men, 4029 women) who underwent a comprehensive medical examination were enrolled in this study. Subjects diagnosed with either diabetes mellitus, or any other disorder that could influence their insulin sensitivity, were rejected. Anthropometry, metabolic risk factors, hepatitis B surface antigen, hepatitis B surface antibody, hepatitis B core antibody, fasting plasma glucose and insulin were measured for all subjects. Homeostasis model assessment (HOMA), quantitative insulin check index (QUICKI), and Mf(fm) index were used for determining insulin sensitivity. Each participant was categorized into a negative, recovery, or CVHB group. To compare variables between groups, a t-test and/or one-way analysis of variance were used. Partial correlation coefficients were computed to present the association between insulin resistance and other variables. Multiple logistic regression analysis was used to assess the independent association between CVHB and IR.

RESULTS

The mean age of men and women were 48.9 and 48.6 years, respectively. Subjects in the CVHB group had significantly higher waist circumference [(86.0 ± 7.7 cm vs 87.3 ± 7.8 cm, P = 0.004 in men), (78.3 ± 8.6 cm vs 80.5 ± 8.5 cm, P < 0.001 in women)], cystatin C [(0.96 ± 0.15 mg/dL vs 1.02 ± 0.22 mg/dL, P < 0.001 in men), (0.84 ± 0.15 mg/dL vs 0.90 ± 0.16 mg/dL, P < 0.001 in women)], fasting insulin [(5.47 ± 3.38 μU/mL vs 6.12 ± 4.62 μU/mL, P < 0.001 in men), (4.57 ± 2.82 μU/mL vs 5.06 ± 3.10 μU/mL, P < 0.001 in women)] and HOMA index [(1.24 ± 0.86 vs 1.43 ± 1.24, P < 0.001 in men), (1.02 ± 0.76 vs 1.13 ± 0.87, P = 0.033 in women)] compared to control group. The HOMA index revealed a positive correlation with body mass index (BMI) (r = 0.378, P < 0.001), waist circumference (r =0.356, P < 0.001), percent body fat (r = 0.296, P < 0.001), systolic blood pressure (r = 0.202, P < 0.001), total cholesterol (r = 0.134, P < 0.001), triglycerides (r = 0.292, P < 0.001), cystatin C (r = 0.069, P < 0.001) and uric acid (r = 0.142, P < 0.001). The QUICKI index revealed a negative correlation with BMI (r = -0.254, P < 0.001), waist circumference (r = 0-0.243, P < 0.001), percent body fat (r = -0.217, P < 0.001), systolic blood pressure (r = -0.132, P < 0.001), total cholesterol (r = -0.106, P < 0.001), triglycerides (r = -0.205, P < 0.001), cystatin C (r = -0.044, P < 0.001) and uric acid (r = -0.096, P < 0.001). For subjects identified with IR, the odds ratio of an accompanying diagnosis of chronic hepatitis B was 1.534 (95% CI: 1.158-2.031, HOMA index criteria) or 1.566 (95% CI: 1.124-2.182, QUICKI criteria) after adjustment for age, gender, BMI, and amount of alcohol consumption.

CONCLUSION

Our study demonstrates that CVHB is associated with IR. CVHB may need to be monitored for occurrence of IR and diabetes mellitus.

摘要

目的

探讨韩国成年人慢性乙型肝炎病毒(CVHB)与胰岛素抵抗(IR)之间的关系。

方法

共纳入 7880 名接受全面体检的成年人(男性 3851 名,女性 4029 名)。排除患有糖尿病或任何其他可能影响其胰岛素敏感性的疾病的患者。对所有受试者进行人体测量、代谢风险因素、乙肝表面抗原、乙肝表面抗体、乙肝核心抗体、空腹血糖和胰岛素的检测。使用稳态模型评估(HOMA)、定量胰岛素检查指数(QUICKI)和 Mf(fm)指数来确定胰岛素敏感性。将每个参与者分为阴性、恢复或 CVHB 组。为了比较组间的变量,使用 t 检验和/或单因素方差分析。计算偏相关系数以显示胰岛素抵抗与其他变量之间的关联。使用多因素逻辑回归分析评估 CVHB 与 IR 之间的独立关联。

结果

男性和女性的平均年龄分别为 48.9 岁和 48.6 岁。CVHB 组的腰围明显更高[(86.0±7.7cm 与 87.3±7.8cm,P=0.004,男性);(78.3±8.6cm 与 80.5±8.5cm,P<0.001,女性)]、胱抑素 C[(0.96±0.15mg/dL 与 1.02±0.22mg/dL,P<0.001,男性);(0.84±0.15mg/dL 与 0.90±0.16mg/dL,P<0.001,女性)]、空腹胰岛素[(5.47±3.38μU/mL 与 6.12±4.62μU/mL,P<0.001,男性);(4.57±2.82μU/mL 与 5.06±3.10μU/mL,P<0.001,女性)]和 HOMA 指数[(1.24±0.86 与 1.43±1.24,P<0.001,男性);(1.02±0.76 与 1.13±0.87,P=0.033,女性)]与对照组相比。HOMA 指数与体重指数(BMI)(r=0.378,P<0.001)、腰围(r=0.356,P<0.001)、体脂百分比(r=0.296,P<0.001)、收缩压(r=0.202,P<0.001)、总胆固醇(r=0.134,P<0.001)、甘油三酯(r=0.292,P<0.001)、胱抑素 C(r=0.069,P<0.001)和尿酸(r=0.142,P<0.001)呈正相关。QUICKI 指数与 BMI(r=-0.254,P<0.001)、腰围(r=0-0.243,P<0.001)、体脂百分比(r=-0.217,P<0.001)、收缩压(r=-0.132,P<0.001)、总胆固醇(r=-0.106,P<0.001)、甘油三酯(r=-0.205,P<0.001)、胱抑素 C(r=-0.044,P<0.001)和尿酸(r=-0.096,P<0.001)呈负相关。对于被诊断为 IR 的受试者,在调整年龄、性别、BMI 和饮酒量后,慢性乙型肝炎的诊断比值比为 1.534(95%CI:1.158-2.031,HOMA 指数标准)或 1.566(95%CI:1.124-2.182,QUICKI 标准)。

结论

本研究表明,CVHB 与 IR 相关。CVHB 可能需要监测发生 IR 和糖尿病的情况。

相似文献

1
Association of chronic viral hepatitis B with insulin resistance.
World J Gastroenterol. 2012 Nov 14;18(42):6120-6. doi: 10.3748/wjg.v18.i42.6120.
5
Usefulness of the metabolic syndrome criteria as predictors of insulin resistance among obese Korean women.
Public Health Nutr. 2010 Feb;13(2):181-6. doi: 10.1017/S1368980009991340. Epub 2009 Aug 26.
6
Insulin Resistance and N-Terminal Pro-B-Type Natriuretic Peptide Among Healthy Adults.
JAMA Cardiol. 2023 Oct 1;8(10):989-995. doi: 10.1001/jamacardio.2023.2758.

引用本文的文献

2
The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review.
Kaohsiung J Med Sci. 2024 Jan;40(1):6-10. doi: 10.1002/kjm2.12762. Epub 2023 Sep 21.
3
Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
Dig Dis Sci. 2023 Apr;68(4):1605-1614. doi: 10.1007/s10620-022-07695-2. Epub 2022 Oct 13.
4
Hepatitis C is associated with more adverse pregnancy outcomes than hepatitis B: A 7-year national inpatient sample study.
Hepatol Commun. 2022 Sep;6(9):2465-2473. doi: 10.1002/hep4.2002. Epub 2022 Jun 24.
6
[Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):228-237. doi: 10.1007/s00103-021-03482-y. Epub 2022 Jan 11.
8
Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma.
Clin Exp Hepatol. 2020 Sep;6(3):235-242. doi: 10.5114/ceh.2020.99517. Epub 2020 Sep 30.

本文引用的文献

1
Natural history of chronic hepatitis B.
Clin Liver Dis. 2010 Aug;14(3):381-96. doi: 10.1016/j.cld.2010.05.007.
3
Viruses and arthritis: new challenges in diagnosis, therapy, and immunization.
Am J Med Sci. 2010 Jun;339(6):549-56. doi: 10.1097/MAJ.0b013e3181c6440e.
5
The metabolic syndrome.
Lancet. 2010 Jan 16;375(9710):181-3. doi: 10.1016/S0140-6736(09)61794-3.
6
Metabolic syndrome pandemic.
Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36. doi: 10.1161/ATVBAHA.107.151092. Epub 2008 Jan 3.
7
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.
J Gastroenterol Hepatol. 2008 May;23(5):779-82. doi: 10.1111/j.1440-1746.2007.05216.x. Epub 2007 Nov 19.
8
Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Gastroenterology. 2007 May;132(5):1955-67. doi: 10.1053/j.gastro.2007.03.039. Epub 2007 Mar 24.
9
Insulin resistance in chronic hepatitis B and C.
Indian J Gastroenterol. 2006 Nov-Dec;25(6):286-9.
10
Inflammation and insulin resistance.
J Clin Invest. 2006 Jul;116(7):1793-801. doi: 10.1172/JCI29069.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验